Prognostic Prediction for Recurrent/Residual CIN in HSIL Patients After Conization: An Updated Retrospective Study Based on Ambulatory Surgery
Guanxiang Huang,Wenyu Lin,Hangjing Gao,Yuan Ren,Jun Shen,Shuxia Xu,Dabin Liu,Yuanjun Cai,Chengbin Lin,Xite Lin,Tingting Jiang,Binhua Dong,Pengming Sun
DOI: https://doi.org/10.2147/jir.s494622
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Guanxiang Huang, 1– 3, &ast Wenyu Lin, 1– 3, &ast Hangjing Gao, 1– 3 Yuan Ren, 1– 3 Jun Shen, 4 Shuxia Xu, 5 Dabin Liu, 6 Yuanjun Cai, 6 Chengbin Lin, 6 Xite Lin, 1– 3 Tingting Jiang, 1– 3 Binhua Dong, 1– 3 Pengming Sun 1– 3 1 College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, 350001, People's Republic of China; 2 Fujian Key Laboratory of Women and Children's Critical Diseases Research, Fujian Maternity and Child Health Hospital (Fujian Women and Children's Hospital), Fuzhou, Fujian, 350001, People's Republic of China; 3 Fujian Clinical Research Center for Gynecological Oncology, Fujian Maternity and Child Health Hospital (Fujian Obstetrics and Gynecology Hospital), Fuzhou, Fujian, 350001, People's Republic of China; 4 Fujian Provincial Cervical Disease Diagnosis and Treatment Health Center, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, 350001, People's Republic of China; 5 Department of Pathology, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, 350001, People's Republic of China; 6 Department of Gynecology, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, 350001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Pengming Sun; Binhua Dong, Laboratory of Gynecologic Oncology, Department of Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, 350001, People's Republic of China, Tel +86-591-87558732 ; +86-13599071900, Fax +86-591-87551247, Email , ; , Background: There are currently few prognostic models for conization in patients with high-grade squamous intraepithelial lesion (HSIL) because it is a rapid procedure that typically collects less case information. The present study aimed to establish a rapid/accurate postoperative prognostic assessment model for these patients. Methods: This study included 631 nonpregnant participants with HSIL confirmed by histopathology from January 2015 to January 2018. The recurrent/residual cervical intraepithelial neoplasia (CIN) were divided into residual CIN, simple recurrent CIN and recurrent CIN accompanied with CIN progression. The recurrence/residual-free survival (RFS) time was defined as the time span from the time of surgery (baseline) until the first lesion of CIN was detected or the 1-/3-/5-year follow-up endpoint was reached. Results: After LASSO regression selection, the higher platelet-to-lymphocyte ratio (PLR) (OR = 1.006, p = 0.002), positive margin status (OR = 2.451, p = 0.021), HPV-16 (OR = 4.414, p < 0.001), − 18 (OR = 3.040, p = 0.009), − 56 (OR = 10.715, p=0.021), and non-HR-HPV (OR = 2.487, p = 0.028) infection showed significant difference in the Logistic model. And HPV-16 infection (OR = 6.159, p = 0.001) could promote recurrent CIN accompanied with CIN progression. In multivariate Cox regression models, the higher PLR (HR = 1.005/1.005/1.005, p = 0.020/0.002/0.003) and HPV-16 infection (HR = 2.758/2.836/2.674, p < 0.001) showed statistical difference during 1-/3-/5-year follow-up. While gland invasion (p = 0.081), margin status (p = 0.075) and HPV infection genotype (p = 0.150) did not showed statistical difference in multivariate Cox regression models based on LASSO regression. And gland invasion (p = 0.251/0.686) and HPV-58 infection (p = 0.148/0.813) also showed no statistical difference in optimized Logistic regression models. Conclusion: HPV-16, − 18, − 56 and non-HR-HPV infection status can be considered as indicators for recurrent CIN during the 5-year follow-up, especially for HPV-16 infection, which also lead to a CIN recurrence accompanied with disease progression. And the preoperative PLR level, gland invasion, positive margin may be predictors for recurrent/residual CIN during 1-, 3- and 5-year follow-up. Keywords: cervical intraepithelial neoplasia, higher platelet-to-lymphocyte ratio, human papillomavirus, conization, prognosis Cervical cancer and related precancerous lesions seriously endanger female health globally. Although there was a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s due to the widespread of screening and vaccination, about 13,960 new cases and 4310 deaths from cervical cancer were still estimated in the United States in 2023, compared with a number of 604,000 in new cases and 342,000 in dead cases from cervical cancer worldwide in 2020. 1,2 Precancerous cervical lesions pr -Abstract Truncated-
immunology